Nanobiotix appoints new senior clinical development and investor directors
Nanobiotix, a late clinical-stage nanomedicine company, has appointed Dr Mihail Obrocea as the Head of US Clinical Development and Noel Kurdi as the Director of Investor Relations.
Click on this link for more information.
